This company listing is no longer active
V6H Stock Overview
Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Virtus Health Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €5.45 |
52 Week High | €5.65 |
52 Week Low | €3.10 |
Beta | 1.47 |
1 Month Change | 5.83% |
3 Month Change | 2.83% |
1 Year Change | 20.04% |
3 Year Change | 80.46% |
5 Year Change | 45.84% |
Change since IPO | 19.02% |
Recent News & Updates
Recent updates
Shareholder Returns
V6H | DE Healthcare | DE Market | |
---|---|---|---|
7D | 0.9% | -1.1% | 1.4% |
1Y | 20.0% | 0.2% | 7.5% |
Return vs Industry: V6H exceeded the German Healthcare industry which returned -37.8% over the past year.
Return vs Market: V6H exceeded the German Market which returned -20% over the past year.
Price Volatility
V6H volatility | |
---|---|
V6H Average Weekly Movement | 5.3% |
Healthcare Industry Average Movement | 5.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: V6H has not had significant price volatility in the past 3 months.
Volatility Over Time: V6H's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | n/a | Kate Munnings | https://www.virtushealth.com.au |
Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore. The company operates through two segments, Healthcare Services Australia and Healthcare Services International. It provides fertility services, medical day procedure services, and medical diagnostics and pathology services.
Virtus Health Limited Fundamentals Summary
V6H fundamental statistics | |
---|---|
Market cap | €705.23m |
Earnings (TTM) | €19.41m |
Revenue (TTM) | €229.73m |
24.5x
P/E Ratio2.1x
P/S RatioIs V6H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
V6H income statement (TTM) | |
---|---|
Revenue | AU$335.40m |
Cost of Revenue | AU$217.18m |
Gross Profit | AU$118.22m |
Other Expenses | AU$89.89m |
Earnings | AU$28.33m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0.33 |
Gross Margin | 35.25% |
Net Profit Margin | 8.45% |
Debt/Equity Ratio | 28.2% |
How did V6H perform over the long term?
See historical performance and comparison